Efficacy and safety of Vinflunine for advanced or metastatic urothelial carcinoma in routine practice based on the French multi-centre CURVE study.
Fiche publication
Date publication
mars 2016
Journal
BMC cancer
Auteurs
Membres identifiés du Cancéropôle Est :
Dr SPAETH Dominique
Tous les auteurs :
Médioni J, Di Palma M, Guillot A, Spaeth D, Théodore C
Lien Pubmed
Résumé
To retrospectively assess the efficacy and safety of Vinflunine (VFL) under routine conditions and identify overall survival (OS) prognostic factors.
Mots clés
Adult, Aged, Aged, 80 and over, Carcinoma, drug therapy, Disease-Free Survival, Drug-Related Side Effects and Adverse Reactions, classification, Female, Humans, Male, Middle Aged, Neoplasm Metastasis, Platinum, therapeutic use, Retrospective Studies, Urologic Neoplasms, drug therapy, Urothelium, drug effects, Vinblastine, administration & dosage
Référence
BMC Cancer. 2016 Mar;16:217